A significant shift in our drug policy has taken place, as the regulators allow the legalization of psilocybin mushrooms for therapeutic purposes. Before this, these substances were heavily restricted, but a mounting body of evidence suggests they may offer benefits for psychological conditions like depression. This change represents a key step tow